IRIS
VITALE, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.065
EU - Europa 10.312
AS - Asia 5.905
SA - Sud America 1.177
AF - Africa 372
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 29.855
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.904
GB - Regno Unito 2.694
RU - Federazione Russa 2.037
CN - Cina 1.842
SG - Singapore 1.772
IT - Italia 1.766
IE - Irlanda 994
BR - Brasile 962
VN - Vietnam 813
UA - Ucraina 597
SE - Svezia 544
FR - Francia 503
HK - Hong Kong 480
DE - Germania 450
FI - Finlandia 336
KR - Corea 296
ZA - Sudafrica 194
IN - India 174
NL - Olanda 105
TR - Turchia 86
BD - Bangladesh 76
AR - Argentina 70
CA - Canada 66
PL - Polonia 61
IQ - Iraq 59
MX - Messico 58
PK - Pakistan 50
JP - Giappone 49
ES - Italia 39
EC - Ecuador 35
NG - Nigeria 32
BE - Belgio 30
CZ - Repubblica Ceca 29
KE - Kenya 29
ID - Indonesia 28
MA - Marocco 28
VE - Venezuela 28
AT - Austria 24
CI - Costa d'Avorio 24
SA - Arabia Saudita 24
CO - Colombia 19
DZ - Algeria 19
CL - Cile 18
PE - Perù 18
UZ - Uzbekistan 18
JO - Giordania 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
IR - Iran 14
CH - Svizzera 13
TN - Tunisia 13
EG - Egitto 12
PH - Filippine 12
LT - Lituania 11
GR - Grecia 10
UY - Uruguay 10
BY - Bielorussia 9
LB - Libano 9
NP - Nepal 9
PY - Paraguay 9
IL - Israele 8
JM - Giamaica 8
MY - Malesia 8
AL - Albania 7
DK - Danimarca 7
HU - Ungheria 7
BO - Bolivia 6
CR - Costa Rica 6
KZ - Kazakistan 6
RS - Serbia 6
BH - Bahrain 5
ET - Etiopia 5
EU - Europa 5
OM - Oman 5
PA - Panama 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
NO - Norvegia 4
PS - Palestinian Territory 4
RO - Romania 4
SN - Senegal 4
AO - Angola 3
BG - Bulgaria 3
BW - Botswana 3
CY - Cipro 3
HN - Honduras 3
LV - Lettonia 3
TH - Thailandia 3
AM - Armenia 2
CG - Congo 2
DO - Repubblica Dominicana 2
GY - Guiana 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MD - Moldavia 2
Totale 29.826
Salva come PNG Salva come JPEG
Città #
Southend 2.461
Dallas 1.826
Fairfield 1.216
Singapore 1.020
Dublin 979
Ashburn 885
Santa Clara 624
Moscow 568
Woodbridge 567
Jacksonville 476
Wilmington 470
Seattle 467
Chandler 463
Houston 462
Hong Kong 459
Cambridge 420
Hefei 409
Beijing 408
San Jose 357
Siena 354
Ann Arbor 327
Menlo Park 319
Seoul 294
Ho Chi Minh City 246
Princeton 234
New York 231
The Dalles 212
Milan 206
Hanoi 196
Helsinki 195
Los Angeles 182
Johannesburg 181
Lauterbourg 175
Nanjing 153
Council Bluffs 148
Rome 122
Munich 97
San Mateo 87
São Paulo 86
San Diego 74
Dong Ket 73
Dearborn 72
Buffalo 70
Boardman 65
Nanchang 58
Orem 57
Bengaluru 54
Florence 53
Düsseldorf 51
Redondo Beach 47
Columbus 46
Da Nang 46
Frankfurt am Main 45
Shenyang 45
Shanghai 41
London 40
Chicago 38
Warsaw 38
Tokyo 37
Lappeenranta 36
Haiphong 32
Nuremberg 32
Tianjin 32
Abuja 31
Changsha 29
Chennai 29
Guangzhou 29
Izmir 28
Rio de Janeiro 28
Washington 28
Jiaxing 27
Turku 27
Bologna 26
San Francisco 26
Brooklyn 25
Brussels 25
Hebei 25
Abidjan 24
Mexico City 24
Amsterdam 23
Turin 23
Norwalk 21
Olomouc 21
Portsmouth 21
Jinan 20
Kraków 20
Montreal 20
Baghdad 19
Denver 19
Stockholm 19
Belo Horizonte 18
Istanbul 18
Kunming 18
Manchester 18
Atlanta 17
Campinas 17
Phoenix 17
Naples 16
Amman 15
Biên Hòa 15
Totale 20.590
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 862
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 400
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 348
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 344
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 342
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 326
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 312
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 308
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 308
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 291
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 288
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 283
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 280
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 270
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 267
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 266
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 262
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 261
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 258
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 256
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 251
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 244
Weekly oral alendronate in mevalonate kinase deficiency 239
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 238
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 237
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 236
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 235
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 233
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 233
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 230
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 230
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 224
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 222
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 220
Clinical and biochemical landmarks in systemic autoinflammatory diseases 220
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 216
Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined 215
Immunometabolic biomarkers of inflammation in Behçet's disease: Relationship with epidemiological profile, disease activity and therapeutic regimes 215
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 215
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 215
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 214
Working the endless puzzle of hereditary autoinflammatory disorders. 209
Anakinra long-term efficacy and safety in the management of Schnitzler's syndrome and latent tuberculosis infection 206
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 206
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature 204
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease 201
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs) 195
Development and implementation of the AIDA international registry for patients with non-infectious uveitis 195
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 192
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 192
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 191
Development and implementation of the AIDA International Registry for patients with Behçet's disease 190
Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman 186
The hereditary autoinflammatory disorders uncovered 185
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 185
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 184
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review 184
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network 183
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series 183
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study 181
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 180
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 180
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues 179
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up 177
Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma 177
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 177
Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 174
Autoinflammatory diseases 174
Diagnosis and classification of relapsing polychondritis 171
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 171
Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases 170
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 169
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives 167
Serum amyloid-A in Behçet's disease 167
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 165
The role of the F402L allele in the NLRP12-autoinflammatory disorder. Reply to: F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls 165
The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review 164
Ultrasound guided corticosteroids sacroiliac joint injections (SIJIs) in the management of active sacroiliitis: a real-life prospective experience 163
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 163
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 163
Idiopathic inflammatory myopathies: an update on classification and treatment with special focus on juvenile forms 162
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: real-life experience from the international AIDA registry 161
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry 160
Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab 160
Successful use of canakinumab in a patient with resistant Behçet's disease 153
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 152
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network 151
null 150
Evolving Frontiers in the Treatment of Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) Syndrome 149
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 148
Development and implementation of the AIDA international registry for patients with non-infectious scleritis 148
Paraneoplastic arthritides: an up-to-date case-based systematic review 147
Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa 147
Comparing biologic options for the management of Behcet's disease-related uveitis 145
Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis 145
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry 144
Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations 144
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 140
The role of biosimilars in uveitis: Long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors 139
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 137
Totale 21.364
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.452
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021675 0 0 0 0 0 0 0 0 0 264 154 257
2021/20221.922 183 234 119 134 99 36 82 65 142 232 205 391
2022/20231.806 117 151 245 221 168 342 54 140 210 24 78 56
2023/20241.957 78 47 174 109 96 519 550 82 17 68 65 152
2024/20254.862 263 222 530 271 579 301 219 271 340 233 461 1.172
2025/202610.613 850 1.703 1.512 1.399 1.905 479 1.343 434 403 585 0 0
Totale 30.465